Article: Teva Gets FDA Approval for Generic Imitrex Tablets.

Teva Pharmaceutical Industries announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of GlaxoSmithKline's Imitrex Tablets, 25 mg, 50 mg and 100 mg for treatment of acute migraine attacks.

Shipment of the product has commenced.

According to company officials, as one of the first companies to file an ANDA containing a paragraph IV ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!